TCG Advisory Services LLC Purchases 3,137 Shares of Colgate-Palmolive (NYSE:CL)

TCG Advisory Services LLC boosted its position in Colgate-Palmolive (NYSE:CL) by 72.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,448 shares of the company’s stock after acquiring an additional 3,137 shares during the quarter. TCG Advisory Services LLC’s holdings in Colgate-Palmolive were worth $594,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Bailard Inc. grew its holdings in shares of Colgate-Palmolive by 25.2% during the 3rd quarter. Bailard Inc. now owns 7,875 shares of the company’s stock valued at $560,000 after purchasing an additional 1,584 shares during the last quarter. JB Capital LLC increased its holdings in Colgate-Palmolive by 7.4% in the 3rd quarter. JB Capital LLC now owns 49,697 shares of the company’s stock worth $3,534,000 after purchasing an additional 3,436 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Colgate-Palmolive by 2.2% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 253,749 shares of the company’s stock valued at $18,044,000 after purchasing an additional 5,445 shares during the last quarter. Mackenzie Financial Corp boosted its stake in shares of Colgate-Palmolive by 4.7% during the third quarter. Mackenzie Financial Corp now owns 3,837,192 shares of the company’s stock valued at $270,407,000 after purchasing an additional 171,397 shares in the last quarter. Finally, Deane Retirement Strategies Inc. bought a new stake in shares of Colgate-Palmolive during the third quarter worth about $1,776,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. StockNews.com lowered Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. The Goldman Sachs Group started coverage on Colgate-Palmolive in a report on Friday, March 1st. They set a “buy” rating and a $93.00 target price on the stock. Morgan Stanley increased their price target on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Finally, JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research note on Thursday, January 18th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $91.44.

Insider Activity at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, insider Jennifer Daniels sold 5,790 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $83.96, for a total transaction of $486,128.40. Following the transaction, the insider now directly owns 63,236 shares in the company, valued at approximately $5,309,294.56. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. In the last 90 days, insiders sold 159,048 shares of company stock valued at $13,336,846. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Stock Down 0.0 %

NYSE:CL traded down $0.03 during trading hours on Friday, reaching $92.88. The company had a trading volume of 5,432,695 shares, compared to its average volume of 4,878,342. The business’s 50-day simple moving average is $88.35 and its two-hundred day simple moving average is $82.35. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $93.25. The firm has a market cap of $76.20 billion, a price-to-earnings ratio of 29.39, a P/E/G ratio of 3.43 and a beta of 0.40. The company has a quick ratio of 0.28, a current ratio of 1.06 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.73 EPS. On average, equities analysts expect that Colgate-Palmolive will post 3.52 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a $0.50 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.